The University of Hawaii John A. Burns School of Medicine is seeking recently diagnosed patients for a 21-day study.The study is led by Cecilia Shikuma, JABSOM professor of medicine and lead investigator, and researchers hope to find evidence that taking telmisartan, a medication...